Definition

An orally bioavailable inhibitor of three as of yet undisclosed kinases, with potential antineoplastic activity. Upon oral administration, multi-kinase inhibitor LNK01002 inhibits the activity of the three as of yet undisclosed kinases. This may result in antitumor activity in tumor cells in which these kinases are upregulated or dysregulated.